* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download emboj7600663-sup
Community fingerprinting wikipedia , lookup
Gene expression wikipedia , lookup
Ribosomally synthesized and post-translationally modified peptides wikipedia , lookup
Photosynthetic reaction centre wikipedia , lookup
Paracrine signalling wikipedia , lookup
Endogenous retrovirus wikipedia , lookup
Magnesium transporter wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Point mutation wikipedia , lookup
Biochemistry wikipedia , lookup
Interactome wikipedia , lookup
Biochemical cascade wikipedia , lookup
NADH:ubiquinone oxidoreductase (H+-translocating) wikipedia , lookup
Signal transduction wikipedia , lookup
Citric acid cycle wikipedia , lookup
Proteolysis wikipedia , lookup
Western blot wikipedia , lookup
Expression vector wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Structural alignment wikipedia , lookup
Nuclear magnetic resonance spectroscopy of proteins wikipedia , lookup
Protein purification wikipedia , lookup
Protein–protein interaction wikipedia , lookup
Adenosine triphosphate wikipedia , lookup
Oxidative phosphorylation wikipedia , lookup
Protein structure prediction wikipedia , lookup
Metalloprotein wikipedia , lookup
Homology modeling wikipedia , lookup
Supplementary data Material and methods Preparation of the PDK3-L2 complex The cDNA sequence coding the L2 domain (residues 126-233 of human E2p) was amplified from the E2p/E3BP plasmid kindly provided by Dr. Kirill Popov (University of Alabama at Birmingham) and cloned into the pTrcHisB vector (Invitrogen) as described previously (Chuang et al., 2002). The resulting plasmid was transformed into BL21 cells; the cells were grown in LB media at 37 °C. Prior to induction with 0.5 mM IPTG, 0.2 mM lipoic acid was supplemented in the medium to produce lipoylated His6-tagged L2 (Liu et al., 1995), followed by culture for 15 hrs at 30 °C. Harvested cells were sonicated in a lysis buffer containing 100 mM potassium phosphate (pH 8.0), 500 mM NaCl, 0.5% Triton X-100, 1% Tween 20, 20 mM 2-mercaptoethanol, 1 mM benzamideine, 10% glycerol, 1 mM PMSF and 1 mg/ml lysozyme. The resulting cell lysate was centrifuged at 30,000 rpm for 30 min. The supernatant was extracted with Ni-NTA resin (Qiagen); the resin was washed in a column with buffer A containing 50 mM potassium phosphate (pH 7.5), 250 mM KCl, 20 mM 2mercaptethanol, 1 mM benzamidine, 0.1 mM phenylmethylsulfonyl fluoride and 5% glycerol, followed by washing with buffer A containing 10 mM imidazole. Bound proteins were eluted with 250 mM imidazole in the buffer A. L2 domains were further purified with a Superdex 75 gel filtration column (Amersham) equilibrated with buffer A. Fractions containing L2 domains were combined, concentrated and stored at -80 °C. DNA fragments encoding the entire mature sequence of human PDK3 (406 residues) were amplified by RT-PCR using RNA prepared from human skin fibroblast as template. The 1 DNA fragments were cloned into the pTrcHisB vector (Invitrogen), and the entire PDK3 sequence was confirmed by DNA sequencing. The resultant plasmid for expressing the Nterminally His6-tagged PDK3 was transformed into BL21 cells containing the pGroESL plasmid. Expression of PDK3 was induced with 0.5 mM IPTG at 28 °C for overnight. Harvested cells were sonicated in the above lysis buffer. The cell lysate was centrifuged at 30000 rpm for 30 min. The supernatant was mixed with Ni-NTA resin, and bound proteins were eluted with buffer A containing 0.2% octaglucopyranoside and 250 mM imidazole. PDK3 was further purified on Superdex 200 gel filtration column (Amersham) equilibrated with buffer A containing 0.05% octaglucopyranoside. To the purified PDK3 solution, a 3-fold molar excess of lipoylated L2 was added to produce the PDK3-L2 complex. The complex was dialyzed overnight against 50 mM Hepes (pH 7.5), 50 mM KCl and 5%(v/v) glycerol. The PDK3-L2 preparation was concentrated to 15 mg/ml, and DTT was added to a 20 mM final concentration for crystallization. Preparation of MBP-PDK3 fusion protein To construct the plasmid expressing MBP-PDK3 fusion protein, the PDK3 gene was amplified by PCR using the plasmid for His6-tagged wild-type PDK3 as a template. XbaI and HindIII restriction sites were introduced into the 5' and 3' end of DNA fragments, respectively. DNA fragments encoding the PDK3 sequence were subcloned into the XbaI/HindIII site of a pMALc vector (New England BioLabs), followed by transformation into BL21 cells containing the pGroESL plasmid for expressing chaperonins GroEL and GroES. The plasmid for Cterminally truncated MBP-PDK3 (392-406) was created by replacing the codon for proline 392 (5'-CCC-3') for the wild-type PDK3 with a stop codon (5'-TAA-3') using the QuinkChange sitedirected mutagenesis system (Stratagene). After cells were grown at 37 °C for 4 hrs, the 2 expression of MBP-PDK3 (wild-type or truncated protein) was induced with 0.5 mM IPTG at 28°C for overnight. Harvested cells were sonicated in the lysis buffer described above after treatment with lysozyme (1 mg/ml) for 30 min. After centrifugation at 30,000 rpm for 30 min, the supernatant was mixed with amylose resin (New England BioLabs), followed by extensive washing with buffer A. Bound proteins were eluted with buffer A containing 10 mM maltose. Eluted proteins were precipitated by ammonium sulfate (75% of saturation) and further purified on Superdex 200 FPLC gel-filtration column. Other protein preparations Human E1p protein was prepared as described previously (Korotchkina and Patel, 1995). The 60-meric E2p/E3BP core was expressed from the E2p/E3BP plasmid and purified as also described previously (Harris et al., 1997). Structural determination Crystals of the PDK3-L2 complex were produced at 20 °C by vapor diffusion using a reservoir solution containing 100 mM Na-citrate (pH 5.6), 50-80 mM NaKH2PO4 and 1M NaCl. Crystals appeared in one day and grew to a final size of ~ 600 x 600 x 500 m3 in 2 to 3 days. PDK3-L2 crystals were transferred into a stabilizing buffer (pH 5.6) containing 100 mM NaKH2PO4, 1.25 M NaCl, 30%(v/v) glycerol, and 100 mM Na-citrate for 3 to 4 hrs. For crystals of nucleotide-bound complexes, crystals were soaked in the stabilizing buffer containing 10 mM ADP or ATP and 10 mM MgCl2. Crystals were flash-cooled after serial transfers into the stabilizing buffer containing 25%(v/v) glycerol with or without a nucleotide (ADP or ATP) and stored in liquid nitrogen. Diffraction data for the nucleotide-free complex (apo) were collected 3 with a rotating anode (RU-300, Rigaku) and an R-AXIS IV detector (Molecular Structure Corporation). Diffraction data for ADP- and ATP-bound complexes were collected with beamlines 19ID and 19BM in the Structural Biology Center at the Advanced Photon Source (Argonne, IL). The data were processed with MOSFLM (Leslie, 1992) or HKL2000 (Otwinowski and W. Minor, 1997). The crystals exhibit the symmetry of space group P6522. Each asymmetric unit contains one PDK3 monomer bound to one L2 domain. Structures of the PDK3-L2 complex were solved by molecular replacement using the program AMoRe (Navaza, 1994) with a model of PDK3, which was constructed by homologymodeling techniques using the program Swiss-Model (http://swissmodel.expasy.org/repository/sms.php?sptr_ac=Q15120) based on the published PDK2 structure (PDB code: 1JM6) (Steussy et al., 2001). After initial refinements of the PDK3 structure with REFMAC5 (Murshudov et al., 1997), the electron density map was improved using DM (Cowtan and Main, 1996). The NMR structure of L2 (PDB code: 1FYC) (Howard et al., 1998) was fitted in the improved density and re-modeled manually using the program O (Jones et al., 1991). During subsequent refinements, a lipoyl acid, ADP or ATP, a magnesium ion, potassium ions, and water molecules were gradually added. An oxidized dithiolane ring of the lipoyl group did not fit into the electron density map. In contrast, the reduced form of lipoamide (dihydrolipoamide) was successfully fitted in the map without any structural skewness (Figure 4, inset). In the final models, the N-terminal region of PDK3 (residues 1-11 for the ATPbound form; residues 1-12 for both the apo- and the ADP-bound), the ATP lid (residues 311-319 for the ATP-bound; residues 307-319 and 322-323 for the apo- and ADP-bound, respectively), and the C-terminal region of L2 (residues 211-215) were disordered and not included. Data 4 processing and refinement statistics are summarized in Table I. Molecular graphics for structural representations were drawn by PyMOL (DeLano Scientific LLC.). Kinase activity assays by E1p phosphorylation The reaction mixture containing 1 g of E1p protein, 0.2 g of human MBP-PDK3 and increasing concentrations of lipoylated L2 (1-30 M) or 40 nM lipoylated E2p/E3BP in 30 mM Hepes buffer (pH 7.35), 2 mM DTT, 1.5 mM MgCl2, 0.2 mM EGTA were pre-incubated at room temperature for 10 min. The phosphorylation reaction was initiated by adding 0.4 mM [P]ATP (specific activity 1.88 Ci/nmol ATP) to the above reaction mixture. After 2 min, the 32 reaction was terminated by adding the reaction mixture at 1:3 dilution to a concentrated SDSPAGE sample buffer comprising 50 mM Tris-HCl (pH 6.8), 5% (w/v) SDS, 50% (v/v) glycerol, 500 mM DTT, and 1% (w/v) bromophenol blue. The terminated reaction mixture was immediately placed in a 65 ºC water bath for 10 min prior to loading onto a 12% SDS-PAGE gel. After electrophoresis, gels were stained with Coomassie Blue R-250 and vacuum-dried. Quantitative analysis of 32P incorporation to the E1p subunit was carried out by scanning a storage phosphor screen with a Typhoon 9200 Variable Mode Imager (Molecular Dynamics) using ImageQuant software. Binding measurements by isothermal titration calorimetry (ITC) ITC measurements with the active preparation of PDK3 dimers were performed in a VPITC microcalorimeter from MicroCal (Nothampton, MA). Titrations were carried out in 50 mM potassium phosphate buffer (pH 6.3), 50 mM KCl, 10 mM MgCl2, 20 mM -mercaptoethanol at 15 °C. In a typical measurement for nucleotide binding, 36 injections (1 x 4 l + 35 x 8 l) of 5 ATP, ADP or ATPS (75 M) were made into 1.8 ml of the MBP-PDK3 fusion protein (15 M, monomer) in the cell with 180 seconds between two consecutive injections, while the sample was stirred at 316 rpm. In experiments for studying the effect of the L2 domain on nucleotide binding, the L2 was added into both the cell and the injection syringe to the final concentration of 30 M. For L2 binding measurements, the L2 concentration in the syringe was 537 M, and the concentration of wild-type or a truncated PDK3 (392-406) in the cell was 68.2 M (monomers). The resulting ITC isotherms were analyzed by using the MicroCal ORIGIN software package, and the binding constant (KA), the binding heat (H), and apparent number of active binding site (N) were obtained. The concentrations of MBP-PDK3 and L2 were determined by using extinction coefficients 278nm of 114.8 mM-1cm-1, and 11.2 mM-1cm-1, respectively. The concentrations of ATP, ADP and ATPS were determined by using the same extinction coefficient of 260nm of 15.4 mM-1cm-1. Figure legends for supplementary figures Supplementary figure S1 Sequence alignments of human PDK isoforms, BCK and lipoyl domains (A) Sequence alignments of human PDK isoforms and the cognate BCK were carried out with ClustalW (Thompson et al., 1994) and drawn by ESPript (Gouet et al., 1999). Conserved residues are colored in red and similar residues in yellow. The secondary structures of PDK3 and rat BCK are shown above and below the alignments, respectively. Wavy lines indicate disordered regions in crystal structures. The ATP lid and C-terminal tail of PDK3 are indicated by red arrows. Conserved residues participating in the lipoyl-binding pocket are marked with a red asterisk *. Residues that interact with the phosphate group of bound ATP are indicated with a 6 blue asterisk * (cf. supplementary table SI). (B) Sequence alignments of lipoly-bearing domains in human PDC were performed as described above. Sequence designations are as follows: E2pLBD1, the outer lipoyl (L1) domain of E2p; E2p-LBD2, the inner lipoyl (L2) domain of E2p; E3bp-LBD, the lipoyl domain of E3-binding protein. Negative numbers for E2p-LBD1 and E3bp-LBD denote residues in mitochondrial targeting sequences. Secondary structures from the present crystal structure and the published NMR structure (Howard et al., 1998) are shown above and below the aligned sequences, respectively. lip, the lipoyl-lysine residue. Supplementary figure S2 Stereo view of the interface between the N-terminal domain of PDK3 and L2 The N-terminal domain of PDK3 (green) binds L2 (yellow) through hydrophobic and electrostatic interactions. The lipoyl-lysine residue (on top of the figure) and other hydrophobic residues (L140, P142, A174, and I176) surrounding the lipoyl lysine contribute to hydrophobic interactions with conserved residues F22, P26 and V55 as well as side-chain methylene groups of K51 in the N-terminal domain. Conserved acidic residues E162, D164 and E179 and proximal residues E182 and E183 (not shown) of L2 form electrostatic interactions with conserved basic residues R21, K374 and R378 in the lower portion of the PDK3 N-terminal domain. Supplementary figure S3 Stereo views of L2 binding-induced conformational changes that destabilize the ATP lid (A) The ATP binding sites from the PDK3-L2-ADP (green) and PDK2-ADP (pink) structures. For details see the figure legend to Figure 7B in the text. (B) The active sites of the 7 PDK3-L2-ATP (blue) and PDK2-ADP (pink) structures. For details see the figure legend to Figure 7C in the text. 8 Table Supplementary table SI Interactions between phosphate groups of the bound nucleotides and the ATP lid of PDK3 ADP ATP ADP PDK3 Distance (Å) ATP PDK3 Distance (Å) O1 O2 O1 O3 L328 N N251 OD1 F324 O N251 OD1 R254 NH2 3.09 3.26 2.84 3.19 2.70 O1 N251 ND2 N251 OD1 L328 N S306 OG N251 OD1 G323 N G325 N Y326 N G327 N E247 OE1 3.16 2.70 2.91 2.74 3.02 3.27 2.85 2.80 3.28 3.27 O2 O1 O2 O3 O1 O2 Distances were calculated using the program CONTACT in the CCP4 package (Collaborative Computational Project, 1994). Suppementary references Chuang, J.L., Wynn, R.M. and Chuang, D.T. (2002) The C-terminal hinge region of lipoic acidbearing domain of E2b is essential for domain interaction with branched-chain alpha-keto acid dehydrogenase kinase. J Biol Chem, 277, 36905-36908. Collaborative Computational Project, Number 4. (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr, 50, 760-763. Cowtan, K.D. and Main, P. (1996) Phase combination and cross validation in iterated densitymodification calculations. Acta Cryst., D52, 43-48. 9 Gouet, P., Courcelle, E., Stuart, D.I. and Metoz, F. (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics, 15, 305-308. Harris, R.A., Bowker-Kinley, M.M., Wu, P., Jeng, J. and Popov, K.M. (1997) Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate dehydrogenase complex. DNAderived amino acid sequence, expression, and reconstitution of the pyruvate dehydrogenase complex. J Biol Chem, 272, 19746-19751. Howard, M.J., Fuller, C., Broadhurst, R.W., Perham, R.N., Tang, J.G., Quinn, J., Diamond, A.G. and Yeaman, S.J. (1998) Three-dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroenterology, 115, 139-146. Jones, T.A., Zou, J.Y., Cowan, S.W. and Kjeldgaard. (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A, 47, 110-119. Korotchkina, L.G. and Patel, M.S. (1995) Mutagenesis studies of the phosphorylation sites of recombinant human pyruvate dehydrogenase. Site-specific regulation. J Biol Chem, 270, 14297-14304. Leslie, A.G.W. (1992) Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography, 26. Liu, S., Baker, J.C., Andrews, P.C. and Roche, T.E. (1995) Recombinant expression and evaluation of the lipoyl domains of the dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex. Arch Biochem Biophys, 316, 926-940. Murshudov, G., Vagin, A. and Dodson, E. (1997) Refinement of Macromolecular Structures by the Maximum-Likelihood Method. Acta Cryst., D53, 240-255. 10 Navaza, J. (1994) AMoRe: an automated package for molecular replacement. Acta Cryst., A50, 157-163. Otwinowski, Z. and W. Minor, W. (1997) Processing of X-ray Diffraction Data Collected in Oscillation Mode. In C.W. Carter, J.R.M.S. (ed.), Methods in Enzymology. Academic Press, New York, Vol. 276, pp. 307-326. Steussy, C.N., Popov, K.M., Bowker-Kinley, M.M., Sloan, R.B., Jr., Harris, R.A. and Hamilton, J.A. (2001) Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase. J Biol Chem, 276, 37443-37450. Thompson, J.D., Higgins, D.G. and Gibson, T.J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice. Nucleic Acids Res, 22, 4673-4680. 11